Skojarzone zastosowanie kwasu (+)-1,4-dihydro-7-[(3s,4s)-3-metoksy-4-(metyloamino)-1-pirolidynylo]-4-okso-1-(2-tiazolilo)-1,8-naftyrydyno-3-karboksylowego i cytarabiny (Ara-C) do leczenia białaczki
ADELMAN, DANIEL C.,SILVERMAN, JEFFREY A.,MICHELSON, GLENN,SCATENA, CAROLINE DARNE
申请号：
PL07811049
公开号：
PL2049109T3
申请日:
2007.08.02
申请国别(地区):
PL
年份:
2016
代理人:
摘要：
Methods of treating, preventing or managing hematologic disorders, such as leukemia are disclosed. The methods encompass the administration of SNS-595. Also provided are methods of treatment using this compound with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy. In certain embodiments, the method of treatment comprise administering SNS-595 in combination with Ara-C.
